First-pass extracted concept

recombinant subunit Zika vaccines

Candidate: concept label1 source documents4 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

Here, we highlight recent advances in various vaccine platforms that have been developed against ZIKV, including ... recombinant subunit vaccines...

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1review2025MEDDOI PubMed

1 evidence snippet 4 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1clinical progresssupports2025Source 1DOI PubMed

Several Zika vaccine candidates across multiple platforms have progressed into clinical trials.

Claim 2development statussupports2025Source 1DOI PubMed

More than ten years after the 2015-2016 epidemic, there are still no approved Zika virus vaccines.

Claim 3preparedness valuesupports2025Source 1DOI PubMed

Multiple Zika vaccine platforms can be a powerful tool for rapid response to future pandemics.

Claim 4translation barriersupports2025Source 1DOI PubMed

Assessment, licensing, and commercial viability of Zika vaccines are complicated by the current low incidence of infection and uncertainty about future outbreaks.